Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold

Postepy w Kardiologii Interwencyjnej

Volumn 10, Issue 2, 2014, Pages 128-129

  Rama Merchan, Juan Carlos ^a   Mattesini, Alessio ^a   Dall'Ara, Gianni ^a   Di Mario, Carlo ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Bioresorbable vascular scaffold; Chronic total occlusion

Indexed keywords

BIORESORBABLE VASCULAR SCAFFOLD; EVEROLIMUS; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHRONIC TOTAL OCCLUSION; CORONARY ARTERY OCCLUSION; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEFT ANTERIOR DESCENDING CORONARY ARTERY OCCLUSION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; STABLE ANGINA PECTORIS;

EID: 84904013632     PISSN: 17349338     EISSN: 18974295     Source Type: Journal    
DOI: 10.5114/pwki.2014.43521     Document Type: Article

References (3)

1. Ormiston JA, Serruys PW, Regar E. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008; 371: 899-907.
2. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 2012; 33: 16-25.
3. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123: 779-97.